Stay updated on Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Sign up to get notified when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study page now includes expanded MeSH terms and related metadata. This enhances indexing and cross-referencing without changing enrollment, design, or results.
    Difference
    51%
    Check dated 2026-08-16T01:16:29.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.4 to v3.6.5, signaling a newer version of the ClinicalTrials.gov entry. This reflects an update to the page metadata or minor content refinements without altering the study's data or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-08T23:23:15.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.6.4, replacing v3.6.3. This appears to be a minor system update and does not modify the study information.
    Difference
    0.1%
    Check dated 2026-07-25T17:15:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A Publications entry was added, including a PubMed-listed article about the study. A note indicates publications are automatically populated from PubMed.
    Difference
    0.3%
    Check dated 2026-07-11T09:33:43.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added to the page, replacing the previous Revision: v3.6.2. This reflects an internal update to the study record's versioning metadata.
    Difference
    0.1%
    Check dated 2026-07-04T04:15:52.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, signaling a newer version of the page content. This change is a metadata-level update and does not modify the study details or eligibility criteria on the page.
    Difference
    0.1%
    Check dated 2026-06-27T02:58:12.000Z thumbnail image

Stay in the know with updates to Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.